Life Sciences Products & Reviews

This product is a recombinant Mouse antibody that recognizes DOTA. The antibody was expressed in mammalian cells with chemically defined culture media and was purified by affinity chromatography.

Comprehensive circRNA services including design, circularization (e.g., ribozyme/intron-mediated), purification, and analytics to deliver stable, translation-competent RNA with improved durability—supported by process development for research and translational programs.

Recombinant Rabbit Antibody is capable of binding to Hypusine, expressed in Chinese Hamster Ovary cells (CHO).

Recombinant Human Antibody (B20-4) is capable of binding to VEGF, expressed in HEK293 cells. Expressed as the combination of a heavy chain (HC) containing VH from antiVEGF mAb and the CH1-3 region of human IgG1 and a light chain (LC) encoding VL from antiVEGF mAb and CL of human kappa light chain. Exists as a disulfide-linked dimer of the HC and LC heterodimer under non-reducing conditions.

End-to-end viral vector design and construction covering vector/serotype selection, expression-cassette optimization, cloning, packaging, purification, and QC. Supports AAV, lentivirus, adenovirus, HSV, vaccinia, and baculovirus with scalable production and documentation for in vitro/in vivo studies and IND-enabling work.

Eliminate Human Error in Cell Counting

The NucleoCounter® NC-203™ is a high-precision cell counter designed to deliver accurate, fast, and consistent analysis of complex cell samples. As cell types, (co-)culture conditions, and cell-based fill-finish products become increasingly complex, more versatile imaging information is required to maintain a high level of analytical accuracy.

The NucleoCounter® SP-100™ sperm cell counter offers unique ease of use and effective determination of total sperm concentration and viability in semen samples from ejaculates or extended doses. The NucleoCounter® SP-100™ is very simple to operate and the measurements can be performed by operators with only limited training in laboratory work.

Disruptive technology for the characterization of small molecules and fragments. With enhanced sensitivity, expanded thermal options, and advanced microfluidics, the Carterra Ultra™ platform is our most sensitive instrument for interrogating multiple proteins and off-target binding in parallel.

Disruptive Technology for Screening and Characterization. Enhanced sensitivity and fast data collection rate build upon unmatched capabilities in throughput and enable assays such as TPDs/PROTAC®s, kinase, cytokines, DELs, and protein:protein inhibitors.

COMET™ is a fully automated, high-throughput, hyperplex platform for the analysis of Formalin-Fixed, Paraffin-Embedded (FFPE), and frozen tissues.

Tools to acelerate biomarker identification and validation

We partner with you to turn complex concepts into commercially viable life science instruments. Our teams integrate regulatory strategy, DfX optimization, and rigorous testing from day one, ensuring your product is compliant, reliable, and optimized for global scale, accelerating your path to market.

We manage the full, regulated production of your complex devices. Our global facilities offer end-to-end assembly, from circuit boards (PCBA) to final system integration, reinforced by integrated testing and adherence to global quality standards. This delivers predictable quality and reliable supply at scale.

We maximize your product’s lifespan and field reliability through comprehensive post-launch support. Our services include aftermarket repair, refurbishment, and strategic product lifecycle extension (redesigns for obsolescence). This maintains performance and ensures global distribution and inventory management long after the product leaves the factory floor.

We build resilient, cost-effective supply chains for your long-lifecycle products. Through early engagement during design, we mitigate risk, plan for component obsolescence, and ensure a consistent flow of materials. This shields your production schedule from global market volatility and guarantees program sustainment.

NPI is your bridge from final design to high-volume manufacturing. We ensure manufacturing readiness and scalable production through Design for Excellence (DfX) and expert program leadership. We manage rapid prototyping, supply chain build-out, and tailored testing to mitigate launch risks and accelerate time-to-market.

Recombinant or purified CA19-9 antigen, a sialylated Lewis blood group antigen, which is a widely used serum biomarker for pancreatic and gastrointestinal cancers.

High-purity proteins produced through genetic engineering in heterologous expression systems, ensuring consistency, scalability, and reduced lot-to-lot variability for research and development.

Recombinant Human Programmed Death-Ligand 1 (PD-L1/CD274/B7-H1), the primary ligand for PD-1, expressed on tumor and immune cells to suppress anti-tumor immunity.

Recombinant Human Bone Morphogenetic Protein 7 (BMP-7), a TGF-β superfamily member that induces bone and cartilage formation and plays roles in renal development and repair.

An extensive collection of recombinant Cluster of Differentiation (CD) proteins, which are key cell surface markers for immunophenotyping, immune function studies, and therapeutic targeting.

A comprehensive portfolio of high-quality resins, columns, buffers, and accessories essential for the purification and analysis of biomolecules across discovery and process development scales.

Manufactured under strict Good Manufacturing Practice guidelines, these proteins are designed for use in preclinical, clinical, and therapeutic applications where quality and regulatory compliance are paramount.

Custom modification of protein sequences and structures to enhance properties such as stability, activity, solubility, and specificity for therapeutic and industrial applications.